Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2025 Earnings Call Transcript February 11, 2026
Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-2.39 EPS, expectations were $-2.18.
Operator: Thank you for standing by. My name is Jordan, and I’ll be your conference operator today. At time, I’d like to welcome Vanda Pharmaceuticals, Inc. Earnings Conference Call. [Operator Instructions] Thank you. I’d now like to turn the call over to Kevin Moran, Vanda’s Chief...
